Hedy Kindler to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Hedy Kindler has written about Drug Evaluation, Preclinical.
Connection Strength
0.036
-
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma. Cancer Chemother Pharmacol. 2008 Apr; 61(4):549-58.
Score: 0.019
-
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol. 2006 Nov; 17(11):1615-9.
Score: 0.017